Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 5
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review.
Chatzidavid S, Kontandreopoulou CN, Giannakopoulou N, Diamantopoulos PT, Stafylidis C, Kyrtsonis MC, Dimou M, Panayiotidis P, Viniou NA. Chatzidavid S, et al. Among authors: stafylidis c. Adv Hematol. 2024 Feb 23;2024:1370364. doi: 10.1155/2024/1370364. eCollection 2024. Adv Hematol. 2024. PMID: 38435839 Free PMC article. Review.
Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection.
Diamantopoulos PT, Kontandreopoulou CN, Stafylidis C, Vlachopoulou D, Giannakopoulou N, Vardaka M, Mpouhla A, Variami E, Galanopoulos A, Pappa V, Psichogiou M, Hatzakis A, Viniou NA. Diamantopoulos PT, et al. Among authors: stafylidis c. Ann Hematol. 2022 Dec;101(12):2711-2717. doi: 10.1007/s00277-022-05003-6. Epub 2022 Oct 22. Ann Hematol. 2022. PMID: 36271935 Free PMC article.
Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study.
Diamantopoulos PT, Stafylidis C, Vlachopoulou D, Kontandreopoulou CN, Giannakopoulou N, Vardaka M, Mpouhla A, Mastrogianni E, Variami E, Galanopoulos A, Pappa V, Psichogiou M, Hatzakis A, Viniou NA. Diamantopoulos PT, et al. Among authors: stafylidis c. Ther Adv Hematol. 2022 May 23;13:20406207221090150. doi: 10.1177/20406207221090150. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35646300 Free PMC article.
Favorable outcomes of patients with sickle cell disease hospitalized due to COVID-19: A report of three cases.
Tentolouris A, Stafylidis C, Siafarikas C, Dimopoulou MN, Makrodimitri S, Bousi S, Papalexis P, Damaskos C, Trakas N, Sklapani P, Spandidos DA, Georgakopoulou VE. Tentolouris A, et al. Among authors: stafylidis c. Exp Ther Med. 2022 May;23(5):338. doi: 10.3892/etm.2022.11268. Epub 2022 Mar 21. Exp Ther Med. 2022. PMID: 35401804 Free PMC article.
Radiologically suspected COVID-19-associated organizing pneumonia responding well to corticosteroids: A report of two cases and a review of the literature.
Siafarikas C, Stafylidis C, Tentolouris A, Samara S, Eliadi I, Makrodimitri S, Spandidos DA, Mathioudakis N, Karamichalos P, Papalexis P, Chlapoutakis S, Sklapani P, Trakas N, Georgakopoulou VE. Siafarikas C, et al. Among authors: stafylidis c. Exp Ther Med. 2022 May 18;24(1):453. doi: 10.3892/etm.2022.11379. eCollection 2022 Jul. Exp Ther Med. 2022. PMID: 35720626 Free PMC article.
The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia.
Chatzidavid S, Kontandreopoulou CN, Diamantopoulos PT, Giannakopoulou N, Katsiampoura P, Stafylidis C, Dryllis G, Kyrtsonis MC, Dimou M, Panayiotidis P, Viniou NA. Chatzidavid S, et al. Among authors: stafylidis c. Clin Hematol Int. 2023 Jun;5(2-3):92-100. doi: 10.1007/s44228-023-00033-x. Epub 2023 Feb 22. Clin Hematol Int. 2023. PMID: 36811764 Free PMC article.